Global Pharmaceuticals & Biotech Nano Cap Stocks

Allied Biotech

Market Cap: NT$1.6b

Manufactures and sells carotenoids worldwide.

Bioqual

Market Cap: US$49.2m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

PDS Biotechnology

Market Cap: US$49.0m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

Venus Remedies

Market Cap: ₹4.2b

Engages in the pharmaceutical business in India and internationally.

CytomX Therapeutics

Market Cap: US$48.5m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

iAnthus Capital Holdings

Market Cap: CA$67.5m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

ECO Animal Health Group

Market Cap: UK£36.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Citius Oncology

Market Cap: US$47.5m

Focuses on the development of novel targeted oncology therapies.

Adicet Bio

Market Cap: US$46.8m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

Precision BioSciences

Market Cap: US$46.7m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States.

J2KBIO

Market Cap: ₩66.7b

A bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$360.0m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

Covalon Technologies

Market Cap: CA$64.4m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Linical

Market Cap: JP¥6.6b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Kahira Pharmaceuticals & Chemical Industries

Market Cap: ج.م2.3b

Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.

Genetics Generation Advancement

Market Cap: NT$1.5b

Provides genetic testing and informatics services in Taiwan.

Agenus

Market Cap: US$45.0m

A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.

EZZ Life Science Holdings

Market Cap: AU$70.8m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

Oncopeptides

Market Cap: SEK 442.0m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

PanGen Biotech

Market Cap: ₩63.8b

Operates as a biologics company in South Korea.

P&K Skin Research Center

Market Cap: ₩62.4b

Engages in the evaluation and research of dermatological products in South Korea.

Mersana Therapeutics

Market Cap: US$41.3m

A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.

Actinium Pharmaceuticals

Market Cap: US$41.2m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Sirnaomics

Market Cap: HK$313.0m

An RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs.

Taiwan Advance Bio-Pharmaceutical

Market Cap: NT$1.3b

Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.

DV Biomed

Market Cap: NT$1.3b

Manufactures and sells medical-grade skin care products in Taiwan and China.

Relief Therapeutics Holding

Market Cap: CHF 31.0m

A biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of rare metabolic, dermatological, and pulmonary diseases in Switzerland, Europe, North America, and internationally.

Moberg Pharma

Market Cap: SEK 367.5m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Microbix Biosystems

Market Cap: CA$50.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Rekah Pharmaceutical Industry

Market Cap: ₪132.8m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

Medical Developments International

Market Cap: AU$54.6m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Werewolf Therapeutics

Market Cap: US$34.6m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

Scilex Holding

Market Cap: US$34.5m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

Radiopharm Theranostics

Market Cap: AU$52.5m

Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.

Earth Science Tech

Market Cap: US$32.7m

Focuses on health and wellness industry.

MariMed

Market Cap: US$32.5m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.